Corestemchemon Inc

166480

Company Profile

  • Business description

    Corestemchemon Inc is a biopharmaceutical company that researches and commercializes stem cell technology. It has developed NEURONATA-R inj., a stem cell therapy for Lou Gehrig's disease which is a rare incurable disease, for the first ALS treatment. Its stem cell therapeutics for Lou Gehrig's disease have a pipeline of incurable diseases such as lupus, multiple system atrophy, and osteoarthritis, and plans to preoccupy the market by focusing on developing therapies for rare incurable diseases based on a development success reference of stem cell therapy for the Lou Gehrig's disease.

  • Contact

    Pangyo 255 beongil 24 I & C Building, 2nd Floor
    yeonggi-do, Bundang-gu
    Seongnam
    Seoul13486
    KOR

    T: +82 24973711

    http://www.corestemchemon.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    371

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,637.8012.900.15%
CAC 407,787.540.56-0.01%
DAX 4023,939.1899.01-0.41%
Dow JONES (US)42,073.4325.27-0.06%
FTSE 1008,722.353.66-0.04%
HKSE23,573.38315.071.35%
NASDAQ19,178.5377.600.41%
Nikkei 22538,432.98710.581.88%
NZX 50 Index12,281.3180.95-0.65%
S&P 5005,902.7314.180.24%
S&P/ASX 2008,409.8012.900.15%
SSE Composite Index3,363.4523.510.70%

Market Movers